HCV and the hepatic lipid pathway as a potential treatment target von Bassendine, Margaret F, Sheridan, David A, Felmlee, Daniel J, Bridge, Simon H, Toms, Geoffrey L, Neely, R. Dermot G

Volltext

PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism von Bridge, Simon H, Sheridan, David A, Felmlee, Daniel J, Crossey, Mary M.E, Fenwick, Fiona I, Lanyon, Clare V, Dubuc, Geneviève, Seidah, Nabil G, Davignon, Jean, Thomas, Howard C, Taylor-Robinson, Simon D, Toms, Geoffrey L, Neely, R. Dermot G, Bassendine, Margaret F

Volltext

Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles von Felmlee, Daniel J, Sheridan, David A, Bridge, Simon H, Nielsen, Søren U, Milne, Ross W, Packard, Chris J, Caslake, Muriel J, McLauchlan, John, Toms, Geoffrey L, Neely, R. Dermot G, Bassendine, Margaret F

Volltext

Lipoprotein(a) testing in lipid clinics across the UK: Results of a national survey von Ansari, Saleem, Neely, R. Dermot G., Payne, Jules, Cegla, Jaimini

Volltext

Healthy Individuals Carrying the PCSK9 p.R46L Variant and Familial Hypercholesterolemia Patients Carrying PCSK9 p.D374Y Exhibit Lower Plasma Concentrations of PCSK9 von Humphries, Steve E, Neely, R. Dermot G, Whittall, Roslyn A, Troutt, Jason S, Konrad, Robert J, Scartezini, Marileia, Li, Ka Wah, Cooper, Jackie A, Acharya, Jayshree, Neil, Andrew

Volltext

Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate von Graham, Colin A., McIlhatton, Brian P., Kirk, Claire W., Beattie, E. Diane, Lyttle, Kelly, Hart, Padraig, Neely, R. Dermot G., Young, Ian S., Nicholls, D. Paul

Volltext

PCSK9 inhibitors in the prevention of cardiovascular disease von Latimer, James, Batty, Jonathan A., Neely, R. Dermot G., Kunadian, Vijay

Volltext

Lp(a): When and how to measure it von Cegla, Jaimini, France, Michael, Marcovina, Santica M, Neely, R Dermot G

Volltext

HEART UK consensus statement on Lipoprotein(a): A call to action von Cegla, Jaimini, Neely, R.Dermot G., France, Michael, Ferns, Gordon, Byrne, Chris D., Halcox, Julian, Datta, Dev, Capps, Nigel, Shoulders, Carol, Qureshi, Nadeem, Rees, Alan, Main, Linda, Cramb, Robert, Viljoen, Adie, Payne, Jules, Soran, Handrean

Volltext

Phaeochromocytoma and ACTH-dependent cushing's syndrome: tumour crf secretion can mimic pituitary cushing's disease von Lois, Konstantinos B., Santhakumar, Anjali, Vaikkakara, Suresh, Mathew, Sajjan, Long, Anna, Johnson, Sarah J., Peaston, Rovert, Neely, R. Dermot G., Richardson, David L., Graham, James, Lennard, Thomas W.J., Bliss, Richard, Miller, Margaret, Ball, Stephen G., Pearce, Simon H.S., Woods, David R., Quinton, Richard

Volltext

Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity von Sheridan, David A, Bridge, Simon H, Felmlee, Daniel J, Crossey, Mary M.E, Thomas, Howard C, Taylor-Robinson, Simon D, Toms, Geoffrey L, Neely, R. Dermot G, Bassendine, Margaret F

Volltext

Erratum to: PCSK9 inhibitors in the prevention of cardiovascular disease von Latimer, James, Batty, Jonathan A., Neely, R. Dermot G., Kunadian, Vijay

Volltext

How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)? von Catapano, Alberico L., Daccord, Magdalena, Damato, Elaine, Humphries, Steve E., Neely, R. Dermot G., Nordestgaard, Børge G., Pistollato, Michele, Steinhagen-Thiessen, Elisabeth

Volltext

Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research von Kamstrup, Pia R, Neely, R Dermot G, Nissen, Steven, Landmesser, Ulf, Haghikia, Arash, Costa-Scharplatz, Madlaina, Abbas, Cheryl, Nordestgaard, Børge G

Volltext

Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection von Bridge, Simon H, Sheridan, David A, Felmlee, Daniel J, Nielsen, Søren U, Thomas, Howard C, Taylor-Robinson, Simon D, Neely, R Dermot G, Toms, Geoffrey L, Bassendine, Margaret F

Volltext

Pravastatin and the development of diabetes mellitus : Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study von FREEMAN, Dilys J, NORRIE, John, PACKARD, Christopher J, SHEPHERD, James, GAW, Allan, SATTAR, Naveed, NEELY, R. Dermot G, COBBE, Stuart M, FORD, Ian, ISLES, Christopher, LORIMER, A. Ross, MACFARLANE, Peter W, MCKILLOP, James H

Volltext

Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs) von Sheridan, David A, Neely, R. Dermot G, Bassendine, Margaret F

Volltext

Corrigendum to “HEART UK consensus statement on Lipoprotein(a): A call to action” [Atherosclerosis 291 (2019) 62–70] von Cegla, Jaimini, Neely, R. Dermot G., France, Michael, Ferns, Gordon, Byrne, Chris D., Halcox, Julian, Datta, Dev, Capps, Nigel, Shoulders, Carol, Qureshi, Nadeem, Rees, Alan, Main, Linda, Cramb, Robert, Viljoen, Adie, Payne, Jules, Soran, Handrean

Volltext

Study to Improve Cardiovascular Outcomes in high-risk older patieNts (ICON1) with acute coronary syndrome: study design and protocol of a prospective observational study von Kunadian, Vijay, Neely, R Dermot G, Sinclair, Hannah, Batty, Jonathan A, Veerasamy, Murugapathy, Ford, Gary A, Qiu, Weiliang

Volltext

Laboratory investigation of lipoprotein X von G. Neely, R. Dermot, Boot, Christopher S.

Volltext